We’d like to acknowledge the following labs for their help and their work on our studies:

The MR Research Center at the University of Pittsburgh is dedicated to the development and application of magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) for medical and biological research.

7 Tesla (7T) Bioengineering Research Program (7TBRP) and the Radiofrequency (RF) Research Facility at University of Pittsburgh

The PET Research Center is a world-class facility, most recently famous for producing Pittsburgh Compound B, a revolutionary amyloid imaging agent that detects plaques associated with Alzheimer’s disease

The eBRAIN research group coordinates and analyzes studies that focus on the interplay between brain integrity and function in a variety of neuroepidemiological studies.

CNBC leverages the strengths of the University of Pittsburgh in basic and clinical neuroscience and those of Carnegie Mellon in cognitive and computational neuroscience to support a coordinated cross-university research and educational program of international stature.

LACI (lay-see) conducts groundbreaking research to better understand and treat depression in older adults. They are a depression lab affiliated with Vanderbilt University Medical Center, located in Nashville, TN.

The Computational Neuroimaging and Connected Technologies Lab at the University of Illinois Chicago (CoNeCT@UIC) is an interdisciplinary team of researchers and clinicians devoted to improving our understanding of brain connectivity using novel techniques from neuroimaging and computational neuroscience.

Our laboratory is devoted to understanding and enhancing women’s health at midlife and beyond.

The MYHAT project seeks to describe the distribution of Mild Cognitive Impairment (MCI) and related entities, their associated features, their outcomes over time, and the predictors of these outcomes.

UPMC Hillman Cancer Center and the Indiana University Melvin and Bren Simon Cancer Center have developed two treatments that may help breast cancer survivors improve their cognitive function, and our research team wants to learn which of these treatments is more helpful.

Research at the LNCD focuses on brain mechanisms that support the transition to adult-level cognitive control of behavior.

The BBStress Lab is located in the Department of Psychiatry at the University of Pittsburgh and under the direction of Dr. Layla Banihashemi, examines how stress may change the brain and how these changes may influence the body’s response to stress.

Geriatric Psychiatry Neuroimaging (GPN) is interested in the mental heath of the fastest growing population of our communities, the elderly and aging.

The Cognitive-Affective Neuroscience and Development Lab is directed by Dr. Cecile Ladouceur and is part of the University of Pittsburgh’s Psychiatry Department. Research in the lab examines the development of cognitive, emotional and social processes using cognitive and affective neuroscience methods.

The main focus of the Translational Neuropsychopharmacology and Neuroimaging Lab is to examine individual differences in mechanisms of antidepressant treatment response in order to identify new targets for therapeutic interventions. In particular, we are interested in understanding how expectancies and learning mechanisms impact mood improvement using placebos as experimental probes.

The Pittsburgh Center for AI Innovation in Medical Imaging (CAIIMI) was launched in January 2020 and, to date, has engaged 98 members (researchers, clinicians, and outreach members) from 9 different schools at the University of Pittsburgh, the University of Pittsburgh Medical Center, and Carnegie Mellon University.  The Center presents as a unique multi-disciplinary team and uses a convergence approach to integrate distinct expertise to advance the field of medical imaging AI. CAIIMI pursues to lead large-scale research efforts and aims to build strong academic-industry partnership.